Circle Pharma Strengthens Leadership Team to Advance Targeted Macrocycle Cancer Pipeline Circle Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation targeted macrocycle therapeutics for cancer, has announced two leadership appointments designed to support the company’s continued scientific development…
Susan G. Komen to Host Austin MORE THAN PINK Walk to Support Breast Cancer Research and Patient Care Susan G. Komen®, a leading breast cancer organization, is preparing to host the Austin MORE THAN PINK Walk on Sunday, October 25,…
Aptar Pharma and Macquarie University Launch Research Program to Advance Inhaled Biologic Delivery Aptar Pharma, a global provider of drug delivery, dosing and protection technologies and services, has announced a new research collaboration with Macquarie University in Australia to investigate…
Altasciences Supports 4B Healthcare’s RhineX Nasal Rinse Program Toward Phase I Clinical Testing Altasciences has announced that its recent drug product development and manufacturing work for 4B Healthcare Inc. has helped advance the company’s investigational RhineX nasal irrigation therapy into…
CAIRDAC Appoints MedTech Executive Raymond W. Cohen as Board Chairman CAIRDAC, SA, a pre-revenue medical technology company developing an autonomous, leadless and self-powered cardiac pacemaker, has appointed Raymond W. Cohen as chairman of its board of directors. The company said…
Genialis and Inventia Life Science Collaborate to Advance Patient-Relevant Pancreatic Cancer Models Genialis, a therapeutic intelligence company, and Inventia Life Science, a developer of advanced 3D cell model technologies, have announced a collaboration aimed at improving how new pancreatic cancer…
ApalyRx and Vida Health Partner to Expand Cost-Effective, Integrated Weight-Loss Care for Employers ApalyRx, a pharmacy technology platform designed to assess prescriptions in real time and route them to the lowest-cost fulfillment channel available under a health plan benefit, has…
StandardX Raises £10 Million to Build Scalable Isotope Refinery for Medicine and Fusion Energy StandardX, a UK-headquartered European deep technology company founded in 2025, has raised £10 million in seed funding to develop what it describes as the world’s first…
Medincell Partner Teva Presents New Data on Investigational Olanzapine LAI and UZEDY at Psych Congress 2026 Medincell’s partner Teva Pharmaceuticals presented new clinical and real-world data on two long-acting injectable (LAI) antipsychotic treatments incorporating Medincell’s proprietary BEPO® drug delivery technology,…
Novartis’ Cosentyx Receives Positive CHMP Opinion for Polymyalgia Rheumatica in Europe Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for Cosentyx® (secukinumab)…
Merck Launches “Your Hive of Whole Health” Program to Support Whole-Person Well-Being for People Living With HIV Merck (NYSE: MRK), known as MSD outside the United States and Canada, has launched Your Hive of Whole Health, a new multi-year educational…
Sensorion to Host SENS-601 Program Day on GJB2-Related Hearing Loss Gene Therapy Sensorion (FR001401A9Z0 – ALSEN), a clinical-stage biotechnology company focused on developing novel therapies designed to restore, treat, and prevent hearing loss disorders, has announced registration and connection details…